2-216100294-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001142311.2(TMEM169):c.646G>T(p.Val216Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,613,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001142311.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM169 | NM_001142311.2 | c.646G>T | p.Val216Leu | missense_variant | 3/3 | ENST00000437356.7 | NP_001135783.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM169 | ENST00000437356.7 | c.646G>T | p.Val216Leu | missense_variant | 3/3 | 1 | NM_001142311.2 | ENSP00000401305 | P1 | |
TMEM169 | ENST00000406027.2 | c.646G>T | p.Val216Leu | missense_variant | 3/3 | 1 | ENSP00000384100 | P1 | ||
TMEM169 | ENST00000295658.8 | c.646G>T | p.Val216Leu | missense_variant | 3/3 | 2 | ENSP00000295658 | P1 | ||
TMEM169 | ENST00000454545.5 | c.646G>T | p.Val216Leu | missense_variant | 4/4 | 4 | ENSP00000412524 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151736Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 251038Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135648
GnomAD4 exome AF: 0.000110 AC: 161AN: 1461894Hom.: 0 Cov.: 31 AF XY: 0.000105 AC XY: 76AN XY: 727248
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151736Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74046
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | The c.646G>T (p.V216L) alteration is located in exon 4 (coding exon 2) of the TMEM169 gene. This alteration results from a G to T substitution at nucleotide position 646, causing the valine (V) at amino acid position 216 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at